ANDA 74872, held by Chartwell Molecules. Acyclovir.
As of Nov 14, 2026, ANDA 74872 (Acyclovir), held by Chartwell Molecules, was first approved by FDA on Apr 22, 1997, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 22, 1997 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Acyclovir200MG ยท capsule;oral | Acyclovir | Discontinued |
| Sep 13, 2000 | Supplement 3Labeling | Approved | None posted |
| Oct 27, 1998 | Supplement 2Labeling | Approved | None posted |
| Mar 26, 1998 | Supplement 1Labeling | Approved | None posted |
| Apr 22, 1997 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
